Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Fu Hung

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
Expert Review of Vaccines|April 6, 2007
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsShaw-Wei D Tsen, Augustine H Paik, Chien-Fu Hung, et al.
Human Gene Therapy|March 11, 2009
Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Journal of Biomedical Science|November 25, 2010
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activationChao-Yi Wu, Archana Monie, Xiaowu Pang, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Therapeutic human papillomavirus vaccines: current clinical trials and future directionsChien-Fu Hung, Barbara Ma, Archana Monie, et al.
Vaccine|August 26, 2006
A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumorsChien-Fu Hung, Roanne Calizo, Ya-Chea Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Combination of viral oncolysis and tumor-specific immunity to control established tumorsChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Journal of Immunology Research|January 14, 2022
Control of Tumors by Antigen-Specific CD8<sup>+</sup> T Cells through PDL1-Targeted Delivery of Antigenic PeptidePo-Hao Feng, Xiaoxu Wang, Louise Ferrall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
Expert Review of Vaccines|April 6, 2007
Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsShaw-Wei D Tsen, Augustine H Paik, Chien-Fu Hung, et al.
Human Gene Therapy|March 11, 2009
Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Journal of Biomedical Science|November 25, 2010
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activationChao-Yi Wu, Archana Monie, Xiaowu Pang, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Therapeutic human papillomavirus vaccines: current clinical trials and future directionsChien-Fu Hung, Barbara Ma, Archana Monie, et al.
Vaccine|August 26, 2006
A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumorsChien-Fu Hung, Roanne Calizo, Ya-Chea Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Combination of viral oncolysis and tumor-specific immunity to control established tumorsChi-Mu Chuang, Archana Monie, Annie Wu, et al.
Journal of Immunology Research|January 14, 2022
Control of Tumors by Antigen-Specific CD8<sup>+</sup> T Cells through PDL1-Targeted Delivery of Antigenic PeptidePo-Hao Feng, Xiaoxu Wang, Louise Ferrall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 28, 2009
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancerChih-Long Chang, Barbara Ma, Xiaowu Pang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2012
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killingTae Heung Kang, Barbara Ma, Connie Wang, et al.
Human Gene Therapy|July 17, 2008
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potencyBruce Huang, Chih-Ping Mao, Shiwen Peng, et al.
Pageof 27